medigraphic.com
ISSN 0301-696X (Print)
Órgano de difusión del Servicio de Sanidad Militar y del Colegio Nacional de Médicos Militares

2017, Number 3

<< Back Next >>

Rev Sanid Milit Mex 2017; 71 (3)

Prevalence of metabolic syndrome in outpatient service

Pacheco-Armenta MC, Jáquez-Torres JÁ

Language: Spanish
References: 44
Page: 264-275
PDF size: 205.83 Kb.


ABSTRACT

Objective: Determine the prevalence of metabolic syndrome in a sample of patients from the outpatient Regional Military Hospital of Acapulco, Guerrero.
Material and methods: A cross-sectional study was made, conducted in the Regional Military Hospital of Acapulco in Guerrero state, during the period from 21 September 2015 to 25 February 2016 and patients of the outpatient department of the hospital were included. The calculation of the sample with the EPI INFO program, which a database was obtained, a descriptive statistical analysis was developed to meet the MS prevalence in this population and the results were analyzed with the statistical package SPSS Statistics 20.0 IMB.
Results: We recorded a sample of 267 patients. The prevalence obtained according to the criteria of the FID in our sample was 63% (n=162), with a higher percentage of women 52.14% (n=134). The mean age of 54.56 ± 12.37 years in patients with metabolic syndrome, and average age of 42.65 ± 15.78 years in individuals without metabolic syndrome, the age group most representative, in the total sample with or without metabolic syndrome was 51-60 years with 29.1% (n=111), 33% (n=65) 24.9% (n=46) respectively. The mean hip circumference patients with metabolic syndrome was 106.79 ± 10.88, and without metabolic syndrome was 102.03 ± 8.96. The mean waist-hip ratio in the total sample was 0.93 ± 0.50, in individuals with metabolic syndrome was 0.90 ± 0.05 and without metabolic syndrome average was 0.98 ± 0.83.
Conclusion: The metabolic syndrome is one of the most prevalent pathologies in Mexican society. This study shows the factor with the highest incidence is obesity and overweight, since it is a sedentary population, with poor nutrutions habits, resulting in dyslipidemia and predisposition to chronic-degenerative diseases.


REFERENCES

  1. Viteri MP, Castro J. Prevalencia de síndrome metabólico en el personal de la Universidad Internacional del Ecuador, sede principal, periodo 2014-2015. Nutr Hosp 2015;32(6):2684-2691.

  2. Verdú JM. Tratado de Nutrición y Alimentación. 2a ed. España, OE: Oceano Ergon; 2009; p. 1371-1376.

  3. López M, Sosa M, Labrousse N. Síndrome Metabólico. Revista de Posgrado de la VI cátedra de Medicina 2007; 174(07):12-15.

  4. Brown J. Nutrición en las diferentes etapas de la vida. 2a ed. México, MG: McGrawHill; 2006; p. 534-541.

  5. Crepaldi G, Maggi S. Diabetes Voice. Brussels (Bel): International Diabetes Federation; 2015 March. [Actualizado en 2016, Nov; consultado en 2016, Abr 29]. Disponible en https://www.idf.org/sites/default/files/attachments/ article_408_es.pdf.

  6. Zimmet P, Alberti G, Serrano M. Una nueva definición mundial del síndrome metabólico propuesta por la Federación Internacional de Diabetes: fundamento y resultados. Rev Esp Cardiol 2005;58(12):1371-1376.

  7. Lizarzaburu JC. Metabolic syndrome: concept and practical application. An Fac med 2013;74(4):315-20.

  8. Reaven GM. The metabolic syndrome: is this diagnosis necessary?. Am J Clin Nutrition 2006;83(6):1237-47.

  9. Gallagher EJ, Leroith D, Karnieli E. The metabolic syndrome- -from insulin resistance to obesity and diabetes. Med Clin North Am 2011;95(5):855-873.

  10. Acosta García E. Vigencia del Síndrome Metabólico. Acta Bioquím Clín Latinoam 2011;45(3):423-430.

  11. Alberti KG, Zimmet P, Shaw J. Metabolic syndromea new worldwide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006;23:469-480.

  12. IDF. Diabetes Voice. Brussels (Bel): Diabetes and Obesity: Time to Act. International Diabetes Federation (IDF) and International Association for the Study of Obesity (IASO); 2015 March. [Actualizado en 2016, Nov; consultado en 2016, Abr 30]. Disponible en https://www.idf.org/webdata/ docs/MetS_def_update2006.pdf

  13. Kim MY, Baik SK. Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease. Korean J Hepatol 2008;14(1):1-3.

  14. Bergman RN. New concepts in extracellular signaling for insulinaction: the single gate way hypothesis. Recent Progr Horm Res 1999;52:359-385.

  15. Obunai K, Jani S, Dangas GD. Cardiovascular morbidity and mortality of the metabolic syndrome. Med Clin North Am 2007;91(6):1169–1184.

  16. Martínez-Lara E, Flores-Bello P, Alonso-Calamaco ME, Esparza-Rocha G, Garzón-Arruel CI. Prevalencia del síndrome metabólico en población militar que acude a valoración médica anual. Rev Sanid Milit Mex 2007; 61(6) : 361-366

  17. Asem HA, Koutsari C et al. Free Fatty Acid storage in human visceral and subcutaneous adipose tissue: role of adipocyte proteins. Diabetes 2011;60(9): 2300–2307.

  18. Aschner P, Buendia R, Brajkovich I, Gonzalez A, Figueredo R, Juarez XE, et al. Determination of the cutoff point for waist circumference that establishes the presence of abdominal obesity in Latin American men and women. Diab Res Clin Practice 2011;93(2):243-247.

  19. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005; 28; 2745-2749.

  20. Consenso Latinoamericano de la Asociación Latinoamericana de Diabetes (ALAD). Epidemiología, diagnóstico, control, prevención y tratamiento del síndrome metabólico en adultos. Rev Asoc Latinoam Diab. 2010;18(1):25-44.

  21. IDF. International Diabetes Federation Website. Brussels (Bel): The metabolic syndrome; 2015 March. [Actualizado en 2016, Nov; consultado en 2016, Abr 30]. Disponible en https://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf

  22. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009 Oct 20;120(16):1640-5. Disponible en https://www. ncbi.nlm.nih.gov/pubmed/19805654

  23. Salas I, Santiago D et al. Prevalence of Metabolic Syndrome Components in an Urban Mexican Sample: Comparison between Two Classifications. Exp Diabetes Res 2012;202540:1–8.

  24. Aguilar CA, Rojas R, Gómez FJ, Franco A, Olaiz G, Rull JA et al. El síndrome metabólico: un concepto en evolución. Gac Méd Méx 2004;140(2):S41-S8.

  25. Wacher N. Epidemiologia del Síndrome Metabólico. Gac Méd Méx 2009;145(5):384-391.

  26. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin N Am 2004;33:351-375.

  27. Lambert M, Paradis G, O'Loughlin J et al. Insulin resistance syndrome in a representative sample of children and adolescents from Quebec, Canada. Int J Obes Relat Metab Disord 2004;28:833–841.

  28. Chavez N, Almeda P, Motola D. Síndrome metabólico: Aspectos fisiopatológicos e importancia epidemiológica. Médica Sur 2004;11(3):160-169.

  29. Scott M, Grundy H et al. Definition of Metabolic Syndrome. Circulation 2004;109:433-438.

  30. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-Mass Index and Mortality in a prospective cohort of U.S adults. NEJM 1999;341(15):1097-1101.

  31. Ramirez E, Amaud-Viñas MdelR, Deslisle H. Prevalence of the metabolic syndrome and associated lifestyles in adults males from Oaxaca, Mex. Salud Publica Mex-Viñas 2007;49(2):94-102.

  32. Fantuzzi G. Adiponectin and inflammation: consensus and controversy. J Allergy Clin Immunol 2008 Feb;121(2):326- 330.

  33. Golden SH, Folsom AR, Coresh J, Sharrett AR, Szklo M, Brancati F. Risk factor grouping related to insulin resistance and their synergistic effects on subclinical atherosclerosis: the atherosclerosis risk in communities study. Diabetes 2002;51:3069-76.

  34. Haffner SM. Abdominal adiposity and cardiometabolic risk: do we have all the answers?. Am J Med. 2007;120:S10–S17.

  35. Gómez-Dantés O, Sesma S, Becerril VM, Canul FM, Arreola H, Frenk J. Sistema de salud de México. Salud Pública 2011; 53 suple 2:S220-S232.

  36. Cardoso-Saldaña GC, Yamamoto-Kimura l, Medina- Urrutia A, Posadas-Sánchez R, Caracas-Portilla NA, Posadas-Romero C. Obesity or overweight and metabolic syndrome in Mexico City teenagers. Arch. Cardiol. Méx 2010;80(1):12-18.

  37. Marrodan MD, Martinez JR, Sánchez M, Lopez N, Alferez I, Villarino A. Prevalence of the Metabolically Healthy Phenotype in Overweight and Obese Spanish Adults. Rev Esp Cardiol 2016;69(2):216–228.

  38. González-Chávez A, Simental L, Elizondo-Argueta S, Sánchez ZJ, Gutiérrez SG, Guerrero-Romero F. Prevalencia del Síndrome Metabólico. Rev Med Hosp Gen Mex 2008;71(1):11-19.

  39. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365:1415-28.

  40. Shiwaku K, Anuurad E, Enkhmaa B, Kitajima K, Yamane Y. Appropiate BMI for Asian populations. Lancet 2004;363:157-63.

  41. Chacín L, Chacín N, Chapín J. Vigencia del SM. Diabetes Int 2009;1(4):86-98.

  42. Khan R, Buse J, Ferranini E, Stern M. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the study of diabetes. Diabetes Care 2005;28:2289-304.

  43. Park Y, Zhu S, Palaniappan L, Heshka S, Carnethon M, Heymsfield S. Prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003;163:427-436.

  44. Gómez-Pérez R. Cambio en el estilo de vida en Diabetes tipo 2: una leyenda urbana. Rev Venez Endocrinol Metab 2013;11(2):56-58.




2020     |     www.medigraphic.com